A POSSIBLE ROLE OF HEPCIDIN IN INTESTINAL INFLAMMATION.
Michelle Pixioline1, Camila Rubia Christofoletti2, Julia Aun Constantino3
1Universidade Estadual de Campinas, Programa de Pós-Graduação em Farmacologia, Campinas, SP, Brasil.
Hepcidin, a key iron regulator, shows a dual role in intestinal inflammation. It promotes inflammation under normal conditions but acts anti-inflammatorily when lipopolysaccharide (LPS) is present.
Area of Science:
- Gastroenterology
- Immunology
- Cell Biology
Background:
- Hepcidin regulates iron availability for hematopoiesis.
- Hepcidin production increases in experimental colitis and Crohn's disease.
- Intestinal cells and leukocytes are implicated in hepcidin's inflammatory role.
Purpose of the Study:
- Investigate hepcidin's role in intestinal inflammation using HT-29 cells.
- Determine the signaling pathways involved in hepcidin production and action.
Main Methods:
- HT-29 cells were stimulated with IL-6, TNF-α, and LPS to assess hepcidin production.
- Inhibitors for Stat-3 and IκBα phosphorylation were used.
- IL-8 release, NF-κB translocation, and ROS production were measured in response to hepcidin.
Main Results:
- HT-29 cells produced hepcidin in response to IL-6, TNF-α, and LPS.
- Stat-3 and IκBα inhibitors modulated hepcidin production.
- Hepcidin induced IL-8 production and ROS generation in HT-29 cells.
- Hepcidin's effect on IL-8 and NF-κB was context-dependent, showing both pro- and anti-inflammatory actions.
Conclusions:
- Hepcidin is produced by intestinal cells during inflammation.
- Hepcidin exhibits a dual role in intestinal inflammation: pro-inflammatory and anti-inflammatory.
- Hepcidin's modulatory role suggests therapeutic potential in intestinal inflammatory diseases.
Related Concept Videos
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...


